Identification of miR-27b as a Novel Signature from the mRNA Profiles of Adipose-Derived Mesenchymal Stem Cells Involved in the Tolerogenic Response
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of miR-27b as a Novel Signature from the mRNA Profiles of Adipose-Derived Mesenchymal Stem Cells Involved in the Tolerogenic Response
Authors
Keywords
MicroRNAs, Gene expression, T cells, Cell differentiation, Mesenchymal stem cells, Gene ontologies, Small interfering RNAs, Immunosuppressives
Journal
PLoS One
Volume 8, Issue 4, Pages e60492
Publisher
Public Library of Science (PLoS)
Online
2013-04-17
DOI
10.1371/journal.pone.0060492
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- microRNA-27b suppresses mouse MSC migration to the liver by targeting SDF-1α in vitro
- (2012) Mu-Han Lü et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury
- (2011) Chunyan Huang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Stromal cell-derived factor-1 (SDF-1): homing factor for engineered regenerative medicine
- (2011) Ting Ting Lau et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Dedifferentiation-Reprogrammed Mesenchymal Stem Cells with Improved Therapeutic Potential
- (2011) Yang Liu et al. STEM CELLS
- Impact of Enhanced Mobilization of Bone Marrow Derived Cells to Site of Injury
- (2011) Edward J. Hannoush et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: Focusing on neuroprotective effects of stromal cell-derived factor-1α
- (2010) Feifei Wang et al. BMC NEUROSCIENCE
- Physiological variations of stem cell factor and stromal-derived factor-1 in murine models of liver injury and regeneration
- (2010) E. Scott Swenson et al. LIVER INTERNATIONAL
- Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats
- (2010) Junming Tang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Towards computational prediction of microRNA function and activity
- (2010) Igor Ulitsky et al. NUCLEIC ACIDS RESEARCH
- SDF-1α as a therapeutic stem cell homing factor in myocardial infarction
- (2010) Santhosh K. Ghadge et al. PHARMACOLOGY & THERAPEUTICS
- Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications
- (2010) Soufiane Ghannam et al. Stem Cell Research & Therapy
- Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats☆
- (2009) Junming Tang et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- MicroRNAs: key regulators of stem cells
- (2009) Vamsi K. Gangaraju et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Stromal cell derived factor-1 enhances bone marrow mononuclear cell migration in mice with acute liver failure
- (2009) Shi-Zhu Jin et al. WORLD JOURNAL OF GASTROENTEROLOGY
- How Do Mesenchymal Stromal Cells Suppress T Cells?
- (2008) Armand Keating Cell Stem Cell
- Stromal Cell–Derived Factor-1α Is Cardioprotective After Myocardial Infarction
- (2008) Ankur Saxena et al. CIRCULATION
- Adenovirus-mediated stromal cell-derived- factor-1 gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis
- (2008) J. Tang et al. Interactive Cardiovascular and Thoracic Surgery
- Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis
- (2007) Alma Zernecke et al. CIRCULATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More